Cyclohexanecarboxylic acid

Cyclohexanecarboxylic Acid Market Intelligence Report (July 22, 2026)

I. Price Trends
1. Market Average Price
- As of July 11, 2026, the market average price for cyclohexanecarboxylic acid (purity 98–99%) stands at RMB 36,000 per ton, with prices remaining stable recently and no significant fluctuations observed.
- Price by Packaging Specification:
- 25 g package: RMB 30 per bag (Shanghai inventory)
- 100 g package: RMB 48 per bag (Shanghai inventory: 5 bags)
- 500 g package: RMB 155 per bag (Shanghai inventory: 4 bags)
- High-purity grade (GC ≥ 99%), 100 mg package: RMB 220 per bag (Shanghai inventory: 10 bags)

2. Regional Price Differentials and Brand Premium
- Hubei Xinkang Pharmaceutical & Chemical Co., Ltd. (pharmaceutical-grade, purity 99%) does not publicly disclose pricing; however, it emphasizes compliance with China’s GMP standards, stable supply capability, and long-term partnerships with international enterprises including Merck (USA) and SK Group (South Korea), implying substantial brand premium potential.
- Yuanye-brand products (Shanghai inventory) exhibit pronounced price differentiation across packaging sizes—smaller packages (e.g., 100 mg) command significantly higher unit prices than bulk packages (e.g., 500 g), reflecting elevated logistics and repackaging costs associated with small-batch procurement.

II. Supply-Demand Dynamics
1. Supply Side
- Production Capacity Distribution: Major domestic producers include Hubei Xinkang (production bases in Tianmen and Xiantao) and Shandong Qiangsen Chemical Co., Ltd., with capacity concentrated in Central China, possessing both large-scale production capabilities and R&D strength.
- Inventory Levels: Certain specifications face localized tightness in Shanghai (e.g., only 4 bags of 500 g packages remain in stock); however, overall supply remains uninterrupted. Producers can mitigate short-term pressure via credit-term adjustments (K-coefficient).

2. Demand Side
- Downstream Applications:
- Pharmaceutical Sector (40% share): Global population aging and improved healthcare infrastructure in emerging markets drive demand growth; cyclohexanecarboxylic acid serves as a key intermediate in synthesizing antibiotics and anti-inflammatory drugs.
- Flavor & Fragrance and Polymer Materials: Rising consumer preference for natural flavorings boosts demand in food additives and personal care products.
- Regional Consumption: The Asia-Pacific region accounts for 52.1% of global consumption, with China and India as primary growth engines; North America (23.6%) and Europe (19.4%) follow closely.

III. Market Drivers
1. Policy & Environmental Regulations
- Under China’s “Dual Carbon” (carbon peak and carbon neutrality) goals, outdated production capacity is being rapidly phased out, elevating industry concentration—and benefiting leading enterprises such as Hubei Xinkang in expanding market share.
- Stricter environmental regulations compel producers to upgrade manufacturing processes—for example, adopting green catalysts to reduce waste gas, wastewater, and solid waste emissions—thereby raising production costs in the short term but enhancing long-term competitiveness.

2. Cost Pressures
- Raw material price volatility—especially cyclohexane—directly impacts production cost. The benchmark cyclohexane price stood at RMB 7,266.67/ton in July 2025 (year-on-year low), but rebounded to RMB 6,166.67/ton as of July 20, 2026; further trend monitoring is warranted.

3. International Trade
- Export Opportunities: Rapid demand growth in Southeast Asia and the Middle East presents export potential; however, domestic supply pressure remains high, resulting in a year-on-year decline in export volume in 2026—insufficient to alleviate inventory pressure.
- Import Dependence: High-end specifications (e.g., GC ≥ 99%) may still rely on imports; domestic producers must overcome technological bottlenecks to achieve import substitution.

IV. Analysis & Outlook
1. Short-Term Trends
- Price Stability: Current supply-demand equilibrium, coupled with steady end-user demand and absence of large-scale restocking activity, suggests prices will remain narrowly range-bound near RMB 36,000/ton through July–August 2026.
- Inventory Divergence: Small-packaged items (e.g., 100 g, 100 mg) may remain tight due to robust laboratory demand, whereas larger packages (e.g., 500 g) face relatively lower inventory pressure.

2. Medium-Term Risks
- Raw Material Costs: Sustained cyclohexane price rebound could be passed on to cyclohexanecarboxylic acid, squeezing producer margins.
- Environmental Compliance: Smaller manufacturers failing to meet regulatory standards risk forced shutdowns—potentially triggering short-term supply contraction and upward price pressure.

V. Forward Outlook (Q3–Q4 2026)
1. Price Forecast
- Bullish Scenario: If pharmaceutical demand exceeds expectations—for instance, accelerated vaccine development against new SARS-CoV-2 variants boosting intermediate demand—prices may surpass RMB 38,000/ton.
- Bearish Scenario: Should cyclohexane prices surge sharply or export performance remain sluggish, prices could retreat to RMB 34,000/ton.

2. Supply-Demand Structure
- Supply Side: Leading enterprises will consolidate advantages via process innovation and capacity expansion, while smaller players accelerate exit—further increasing industry concentration.
- Demand Side: Pharmaceutical demand is projected to grow at an annual rate of 8–10%; flavor & fragrance and polymer materials segments may achieve faster growth of 12–15%, emerging as new growth poles.

3. Strategic Recommendations
- Producers: Optimize production processes to reduce costs and expand into high-value-added downstream applications (e.g., specialty polymers).
- Traders: Monitor regional price differentials and leverage strategic warehousing hubs (e.g., Shanghai, Hubei) to build efficient distribution networks.
- Investors: Prioritize investment in leading enterprises holding GMP certification and export qualifications; avoid exposure to small-scale manufacturers lacking environmental compliance.